San Francisco, CA, United States of America

Rae Lyn Burke

This inventor holds 23 USPTO granted patents, primarily in Viral Vaccine Development. Top assignees: Chiron Corporation, Novo Nordisk A/s, Board of Trustees of Leland Chiron Corporation. Active years: 1986-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rae Lyn Burke. Retrieved from https://idiyas.com/inventor/rae-lyn-burke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 16

Forward Citations = 848(Granted Patents)


Company Filing History:


Years Active: 1986-2009

Loading Chart...
Areas of Expertise:
Bioadhesive Delivery
Transmucosal Delivery
Factor VIII:C
Herpes Simplex Virus
Viral Proteins
Nucleic Acid Molecules
Recombinant Vaccines
Diagnostics
Protein Complexes
Eukaryotic Transcription
Glycoprotein B
Glycoprotein D
23 patents (USPTO):Explore Patents

Title: Innovator Rae Lyn Burke: Pioneering Transformative Solutions

Introduction

Rae Lyn Burke, based in San Francisco, CA, is an accomplished inventor with a remarkable portfolio of 23 patents. His groundbreaking work primarily focuses on innovative biomaterials and genetic engineering. Burke's contributions have significantly advanced the fields of drug delivery systems and recombinant DNA technology.

Latest Patents

Among Burke's latest patents is a bioadhesive delivery system designed for transmucosal delivery of beneficial agents. This invention combines pH-responsive and temperature-responsive components to create formulations that exhibit bioadhesive properties, making them suitable for delivering various beneficial agents through mucous membranes.

Another significant patent is related to Factor VIII:C nucleic acid molecules, which details methods and compositions for the recombinant DNA production of Factor VIIIC and its truncated derivatives. This invention includes the development of probes for isolating messenger RNA, cDNA, or chromosomal DNA encoding Factor VIIIC, leading to enhanced methods for expression in host systems.

Career Highlights

Throughout his career, Rae Lyn Burke has worked with leading organizations like Chiron Corporation and Novo Nordisk A/S, where he has had the opportunity to apply his innovative mindset. His extensive experience and expertise have made him a notable figure in the realm of biotechnology.

Collaborations

During his tenure, Burke has collaborated with esteemed colleagues such as Pablo D. Valenzuela and Carol A. Pachl. These partnerships have helped to foster an environment of creativity and innovation, further propelling forward the development of impactful technologies.

Conclusion

Rae Lyn Burke's significant contributions to the fields of drug delivery and genetic engineering, underscored by his extensive patent portfolio, mark him as a true innovator. His work continues to influence advancements in health care and biotechnology, showcasing the vital role of inventors in shaping the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…